GW Pharmaceuticals
GW Pharmaceuticals Limited is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals. Provided by Wikipedia-
1Contributors: “...GW Pharmaceuticals...”
Get access
Get access
Get access
Article in Journal/Newspaper